Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Harvard Business School

Generated: December 12, 2017

DrugPatentWatch Database Preview

Hyaluronidase - Generic Drug Details

« Back to Dashboard

What are the generic sources for hyaluronidase and what is the scope of hyaluronidase patent protection?

is the generic ingredient in five branded drugs marketed by Amphastar Pharm, Akorn Inc, Bausch And Lomb, Baxter Hlthcare, and Halozyme Therap, and is included in five NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for hyaluronidase. Four suppliers are listed for this compound.

Pharmacology for hyaluronidase

Ingredient-typeGlycoside Hydrolases
Drug ClassEndoglycosidase
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Baxter HlthcareWYDASEhyaluronidaseINJECTABLE;INJECTION006343-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Akorn IncHYDASEhyaluronidaseINJECTABLE;INJECTION021716-001Oct 25, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Bausch And LombVITRASEhyaluronidaseINJECTABLE;INJECTION021640-002Dec 2, 2004RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Amphastar PharmAMPHADASEhyaluronidaseINJECTABLE;INJECTION021665-001Oct 26, 2004RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Bausch And LombVITRASEhyaluronidaseINJECTABLE;INJECTION021640-001May 5, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Halozyme TherapHYLENEX RECOMBINANThyaluronidase recombinant humanINJECTABLE;INJECTION021859-001Dec 2, 2005RXYesYes► Subscribe► Subscribe► SubscribeYY► Subscribe
Baxter HlthcareWYDASEhyaluronidaseINJECTABLE;INJECTION006343-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Baxter HlthcareWYDASEhyaluronidaseINJECTABLE;INJECTION006343-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Argus Health
Daiichi Sankyo
Cantor Fitzgerald
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: